Biometrics

Centralized Biometrics

Effective Vendor Oversight Strategy

Increase quality, improve efficiency and cost savings thanks to an outsourcing model that highlights data as an asset and keeps all data related activities with one specialized vendor. This model creates considerable costs savings through standardization and improved efficiency. This yields a streamlined approach to oversight as required by ICH E6 (R2), consistent data strategy and handling and faster integration to support regulatory filings.

Key Elements of Centralized Biometrics

Improved Efficiency

  • Re-use of existing CRF pages to save on database build and statistical programming costs
  • Creation of global libraries of CRF pages and programs/macros
  • Utilization of one set of technologies so CRAs and Investigational Site staff benefit from familiarity
  • Better integration of studies across all phases with common assessment methods and increased efficiciency at time of reporting or regulatory filing
  • Centralized portal for viewing study data that facilitates data exploration, deployment of data visualization, and reporting across studies
  • Central warehouse for all clinical trial data and biometrics documents

Considerable Cost Savings

  • Volume discounts for EDC licensing fees and centralized hosting
  • Potential for FSP approach to all studies, creating additional cost savings

Maximized Partnerships

  • Enhanced understanding of your organization, needs and structure
  • Stable teams built on mutual understanding of working practices and shared vision
  • Development of tailored strategies and processes to meet your needs and expectations

Why choose Alira Health?

The CROS NT and Alira Health biometrics team has provided expert statistical guidance for over 500 projects, including regulatory communication and submissions, study-based data management, biostatistics, and statistical programming. You will benefit from our:

  • Leadership with in-depth industry knowledge from our expert biostatistician with more than 20 years of experience
  • Dedicated, experienced in-house data specialists, with an average of over 10 years of industry experience
  • Tiered governance approach designed to mitigate risks, guarantee quality, and improve efficiency of project teams

Related News

Multimedia May 19, 2022
Fireside Chat Replay: Latest Developments in Oncology Supportive Care
In this fireside chat, we sit down with two medical experts in oncology and discuss some of the fascinating developments that are happening in the oncology supportive care field.
Clinical
Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Life Sciences Regulatory
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
Multimedia April 28, 2022
Alira Health’s Transformation Talks: Real-World Data to Support HTAs in Europe
Learn more about RWD as a support in HTAs and its direct impact on HTAs budgets, results, and even patient outcomes by listening to this episode of Transformation Talks.
Clinical Market Access RWE
Multimedia April 15, 2022
Alira Health’s Transformation Talks: Real-World Evidence Strategy Playbook
As a special guest, our episode “Real-World Evidence Strategy Playbook” with Romain Finas, Vice President of Real-World Evidence at Alira Health, is now live! Listen to this podcast(...)
Clinical RWE
Multimedia April 13, 2022
Fireside Chat Replay: Clinical Trials in Rare Disease: Best Practices for Integrating the Patient Voice
This webinar will focus on the U.S. FDA and EU MDR/IVDR regulatory pathways and strategies for medical device startups based in the Asia Pacific.
Clinical Patient Engagement
Events April 12, 2022
SCOPE Europe 2022
We are thrilled to announce that this year we will be joining the 4th Annual Summit for Clinical Trials Operations Executives Europe (SCOPE Europe).
Clinical
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.